Cirrhosis

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Cirrhosis Presenting as Cutaneous Calciphylaxis

Oct. 11, 2017

A 73-year-old woman with a history of hypertension presented with a 3-month history of a painful, non-healing right calf ulcer and 2–3 weeks of painful, dusky purple patches on the right thigh.

Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Oct. 11, 2017

Statin use is probably associated with lower risk of hepatic decompensation and mortality, and might reduce portal hypertension, in patients with CLDs.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.

Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis

Aug. 24, 2017

We performed a systematic review and meta-analysis to determine the effects of anticoagulant therapy in patients with cirrhosis and PVT.
Advertisement

Anticoagulants in Cirrhosis & Portal Vein Thrombosis

Aug. 1, 2017

Dr. Francesco Violi discusses his manuscript "Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis" for the August issue of Gastroenterology. To view: http://bit.ly/2tXrYjG.

Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis

Aug. 1, 2017

We performed a systematic review and meta-analysis to determine the effects of anticoagulant therapy in patients with cirrhosis and PVT.

Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life

Aug. 1, 2017

We investigated the prevalence of disturbed sleep, factors associated with sleep disruption, and effects on quality of life.

Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis

June 22, 2017

We found that urine levels of IL18 and NGAL from patients with cirrhosis discriminate between those with ATN and other types of kidney impairments.

Member Benefit Spotlight: GastroSlides

June 15, 2017

Free access to AGA's GastroSlides is now a member benefit.

Digestive Disease Week® (DDW)

May 6, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Cholelithiasis and Biliary Cirrhosis in a 28-Year-Old Man

April 29, 2017

A 28-year-old man was referred for liver transplantation for decompensated liver disease.

Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation

April 1, 2017

We compared data on disease prevalence in the population with data from liver transplantation waitlists.

Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities

Feb. 1, 2017

We conducted a phase 4, open-label study with limited exclusion criteria to evaluate the safety and efficacy of sofosbuvir and ribavirin in veterans with hepatitis C virus genotype 2 infection, and compensated cirrhosis.

Eradication of HCV in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Jan. 23, 2017

This MedPage Today AGA Reading Room article reviews the effects of a sustained viral response on outcomes of patients with HCV.

Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites

Jan. 2, 2017

We performed a randomized controlled trial to determine the effects of TIPS with stents covered with polytetrafluoroethylene in these patients.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Jan. 2, 2017

We performed a prospective study to investigate the effects of SVR on outcomes of patients with HCV infection and compensated cirrhosis.

Highlighted Abstracts from the International Digestive Disease Forum

Dec. 21, 2016

CGH features 104 abstracts from the 2016 meeting, which took place in Hong Kong.

AGA Congratulates Academy of Educators Grant Awardees

Dec. 9, 2016

Recipients will get $1,000 to fund the development of teaching materials and tools in the fields of gastroenterology or hepatology.

Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis

Nov. 22, 2016

This large cohort study showed that therapy is safe and effective in patients with compensated (CP score of A) cirrhosis.

The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis

Nov. 1, 2016

This review provides an overview of the lymphatic vascular system in the liver.

GI Patient Education Materials at Your Fingertips

Oct. 31, 2016

As an AGA member, you have free, quick and easy access to the new AGA Patient INFO Center’s robust library of GI patient education materials.